David Windley
Stock Analyst at Jefferies
(3.63)
# 823
Out of 5,113 analysts
199
Total ratings
66.67%
Success rate
14.46%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgrades: Buy | $253 → $313 | $259.40 | +20.66% | 19 | Dec 5, 2025 | |
| DEO Diageo | Downgrades: Neutral | n/a | $89.16 | - | 1 | Dec 3, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $327.42 | +24.92% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $568.36 | -20.82% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $220.69 | +1.95% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $173.77 | +0.71% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $17.74 | -46.45% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $197.06 | -1.05% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $254.34 | +3.40% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.33 | +106.77% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $39.02 | +56.33% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $14.90 | -19.46% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $271.89 | +55.21% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $163.69 | +81.44% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.67 | +461.29% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $340.69 | +77.29% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $572.47 | -34.49% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $17.17 | -9.73% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $221.86 | +21.70% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.07 | +70.89% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $272.54 | +96.67% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $20.53 | +41.26% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.23 | +3,330.15% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.36 | - | 5 | Oct 9, 2017 |
Humana
Dec 5, 2025
Upgrades: Buy
Price Target: $253 → $313
Current: $259.40
Upside: +20.66%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $89.16
Upside: -
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $327.42
Upside: +24.92%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $568.36
Upside: -20.82%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $220.69
Upside: +1.95%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $173.77
Upside: +0.71%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $17.74
Upside: -46.45%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $197.06
Upside: -1.05%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $254.34
Upside: +3.40%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.33
Upside: +106.77%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $39.02
Upside: +56.33%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $14.90
Upside: -19.46%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $271.89
Upside: +55.21%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $163.69
Upside: +81.44%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.67
Upside: +461.29%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $340.69
Upside: +77.29%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $572.47
Upside: -34.49%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $17.17
Upside: -9.73%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $221.86
Upside: +21.70%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.07
Upside: +70.89%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $272.54
Upside: +96.67%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $20.53
Upside: +41.26%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.23
Upside: +3,330.15%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.36
Upside: -